OVERLAND PARK, Ks., January 15, 2021 – Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based in Hong Kong, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Dr. Loong holds conjoint appointments of Clinical Assistant Professor in the department of clinical […]
Read MoreRace Oncology announced recently that it has appointed George Clinical to scope and cost a proof-of-concept Phase I/II breast cancer clinical trial of Bisantrene in combination with cyclophosphamide. This program will enable the Race Oncology Board to make a fully informed and costed decision on this important clinical pathway before expending significant shareholder funds. Bisantrene […]
Read MoreGeorge Clinical team members recently participated in the 12th Annual DIA China Meeting, the largest Chinese event in the life sciences industry. The conference is designed to “foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies in the APAC region.” Around 3,000 pharmaceutical R&D professionals […]
Read MoreOVERLAND PARK, Ks., October 8, 2020 – Abby Abraham, a veteran clinical researcher and data science lead, has joined George Clinical, a global scientifically-backed clinical research organization, to head up the organization’s Global Data Science team and operations in India. Abraham, a progressive clinical research professional passionate about altering the existing clinical research execution paradigm […]
Read MoreOVERLAND PARK, Ks., September 21, 2020 – Dipti Talaulikar, MBBS, PhD, a clinician and researcher with extensive involvement in hematology, has joined George Clinical, a global scientifically-backed clinical research organization, as a member of the organization’s scientific leadership. In addition to her new role as a scientific leader with George Clinical, Dr. Talaulikar is also […]
Read MoreMedlab Clinical, a company with a portfolio of novel drug candidates including cannabinoids and nutraceuticals, enhanced by its drug delivery platform and used for the treatment of chronic pain and disease, announced that it has signed an agreement with George Clinical to provide clinical services support for Medlab’s upcoming NanaBis™ Phase III trials. The Phase […]
Read MoreOVERLAND PARK, Ks., September 2, 2020 – George Clinical, a global scientifically-backed clinical research organization, has expanded the organization’s team in China with the addition of Dr. Zhenfei Yin in the role of Country Head and Regional Head of Project Operations. Zhenfei will be responsible for leading operations teams across China. Zhenfei brings nearly a […]
Read MoreOVERLAND PARK, Ks., August 18, 2020 – Alta Schutte, Ph.D., an expert researcher in hypertension and cardiovascular disease has joined George Clinical, a global scientifically-backed clinical research organization, as a member of the organization’s scientific leadership team. Schutte serves as Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the faculty of medicine at […]
Read MoreSimon Finfer, professorial fellow in the Critical Care and Trauma Division at The George Institute, was recently appointed an Officer of the Order of Australia (General Division) in the Queen’s Birthday Honors list. Dr. Finfer, a critical care physician, has been working with The George Institute for 20 years and during that time has led […]
Read MoreThe following article is written by George Clinical’s CMO, Maria Ali. When outcomes are all that drive us we miss out on many important opportunities. There has been a clear paradigm shift over the last few decades with regard to patients’ role in their medical care and treatment options. The old system whereby a […]
Read More
